Release Date: July 11, 2025
Expiration Date: July 11, 2026
Activity Overview
This educational activity is an archive of the live presentation held on Friday, May 30, 2025.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward physicians, nurses, nurse practitioners, physician assistants, and other health care providers involved in the treatment and management of NSCLC.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify optimal molecular testing strategies for individual categories of MET dysregulation in patients with NSCLC along the continuum of care
- Assess safety and efficacy results from clinical trials investigating MET-targeted approaches for the management of patients with advanced NSCLC
- Determine the mechanistic rationale supporting the role of emerging therapies targeting c-MET overexpression
- Analyze ongoing trials as well as emerging data for novel strategies targeting c-MET overexpression in patients with NSCLC with or without EGFR mutations

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here